Edesa Biotech (EDSA) Liabilities and Shareholders Equity (2013 - 2026)
Edesa Biotech (EDSA) posted Liabilities and Shareholders Equity of $12.72 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 14.1% from $14.8 million a year earlier.
Powered by 
Analysis
Edesa Biotech (EDSA) Liabilities and Shareholders Equity (2013 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Edesa Biotech's Liabilities and Shareholders Equity came in at $13.53 million, up 254.8% from FY2024.
- Annual Liabilities and Shareholders Equity shows a five-year compound annual growth rate of 4.7% (FY2020 to FY2025).
- In prior fiscal years, Edesa Biotech's Liabilities and Shareholders Equity was $3.81 million in FY2024 (-57.1%), $8.89 million in FY2023 (-23.2%), $11.58 million in FY2022 (-20.6%) and $14.58 million in FY2021 (+35.5%).
- The fiscal Q3 2026 figure stands as the lowest quarterly Liabilities and Shareholders Equity since fiscal Q1 2025.
- On a year-over-year basis, Liabilities and Shareholders Equity increased in four of the last seven quarters, with growth averaging 103.9%.
- The strongest year-over-year quarter for Liabilities and Shareholders Equity in the past five years was fiscal Q4 2025, with growth of 254.8%; the weakest was fiscal Q4 2024, with a decline of 57.1%.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,163.39 Bn | 1,131.97 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 634.39 Bn | 552.91 Bn | 17.26 Bn | 201.06 Bn |
| 3 | AbbVie | 502.68 Bn | 475.79 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 377.37 Bn | 331.74 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 303.41 Bn | 267.40 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 266.55 Bn | 240.24 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 240.56 Bn | 195.96 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 193.19 Bn | 167.38 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.14 Bn | 118.78 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Edesa Biotech | 26.61 Mn | -18.92 Mn | - | 12.72 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12.72 Mn |
| Dec 31, 2025 | 14.71 Mn |
| Sep 30, 2025 | 13.53 Mn |
| Jun 30, 2025 | 14.80 Mn |
| Mar 31, 2025 | 16.45 Mn |
| Dec 31, 2024 | 4.16 Mn |
| Sep 30, 2024 | 3.81 Mn |
| Jun 30, 2024 | 5.23 Mn |
| Mar 31, 2024 | 6.48 Mn |
| Dec 31, 2023 | 7.83 Mn |
| Sep 30, 2023 | 8.89 Mn |
| Jun 30, 2023 | 9.42 Mn |
| Mar 31, 2023 | 10.67 Mn |
| Dec 31, 2022 | 11.67 Mn |
| Sep 30, 2022 | 11.58 Mn |
| Jun 30, 2022 | 17.54 Mn |
| Mar 31, 2022 | 20.41 Mn |
| Dec 31, 2021 | 12.34 Mn |
| Sep 30, 2021 | 14.58 Mn |
| Jun 30, 2021 | 16.88 Mn |
API Access
Edesa Biotech Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EDSA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "EDSA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=EDSA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();